Tat is required for efficient HIV-1 reverse transcription

EMBO Journal

Volumn 16, Issue 6, 1997, Pages 1224-1235

  Harrich, David ^a   Ulich, Catherine ^a   García Martínez, León F ^a   Gaynor, Richard B ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Htv 1; Reverse transcription; Tat protein

Indexed keywords

LYSINE TRANSFER RNA; RNA DIRECTED DNA POLYMERASE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; RNA BINDING; VIRION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL LINE; DEFECTIVE VIRUSES; DNA PRIMERS; DNA, VIRAL; GENE DELETION; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAT; GENES, TAT; GENETIC COMPLEMENTATION TEST; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; TRANSCRIPTION, GENETIC; TRANSFECTION; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030957531     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.6.1224     Document Type: Article

References (76)

1. Aboul-ela, F., Karn, J. and Varani, G. (1995) The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. J. Mol. Biol., 253, 313-332.
2. Aiyar, A., Cobrinik, D., Ge, Z., Kung, H.J. and Leis, J. (1992) Interaction between retroviral U5 RNA and the psi C loop of the tRNA (Trp) primer is required for efficient initiation of reverse transcription. J. Virol., 66, 2464-2472.
3. Aiyar, A., Ge, Z. and Leis, J. (1994) A specific orientation of RNA secondary structures is required for initiation of reverse transcription. J. Virol., 68, 611-618.
4. Allain, B., Lapadat-Tapolsky, M., Berlioz, C. and Darlix, J.-L. (1994) Transactivation of the minus-strand DNA transfer by nucleocapsid protein during reverse transcription of the retroviral genome. EMBO J., 13, 973-981.
5. Arts, E.J., Li, X., Gu, Z., Kleiman, L., Parniak, M.A. and Wainberg, M.A. (1994) Comparison of deoxyoligonucleotide and tRNA (Lys-3) as primers in an endogenous human immunodeficiency virus type-1 in vitro reverse transcription/template-switching reaction. J. Biol. Chem., 269, 14672-14680.
6. Arts, E.J., Ghosh, M., Jacques, P.S., Ehresmann, B. and Le Grice, S.F.J. (1996a) Restoration of tRNA3Lys-primed (-)-strand DNA synthesis to an HIV-1 reverse transcriptase mutant with extended tRNAs. J. Biol. Chem., 271, 9054-9061.
7. Arts, E.J. et al. (1996b) Initiation of (-) strand DNA synthesis from tRNA3Lys on lentiviral RNAs: implications of specific HIV-1 RNA-tRNA3Lys interactions inhibiting primer utilization by retroviral reverse transcriptases. Proc. Natl Acad. Sci. USA, 93, 10063-10068.
8. Baltimore, D. (1970) RNA-dependent DNA polymerization in virions of RNA tumor viruses. Nature, 226, 1209-1211.
9. Barat, C., Schatz, O., Le Grice, S. and Darlix, J.L. (1993) Analysis of the interactions of HIV-1 replication primer tRNA(Lys3) with nucleocapsid protein and reverse transcriptase. J. Mol. Biol., 231, 185-190.
10. Berkhout, B., Silverman, R.H. and Jeang, K.T. (1989) Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell, 59, 273-282.
11. Braaten, D., Franke, E.K. and Luban, J. (1996) Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol., 70, 3551-3560.
12. Calnan, B.J., Tidor, B., Biancalana, S., Hudson, D. and Frankel, A.D. (1991) Arginine-mediated RNA recognition: the arginine fork. Science, 252, 1167-1171.
13. Cobrinik, D., Soskey, L. and Leis, J. (1988) A retroviral RNA secondary structure required for efficient initiation of reverse transcription. J. Virol., 62, 3622-3630.
14. Cobrinik, D., Aiyar, A., Ge, Z., Katzman, M., Huang, H. and Leis, J. (1991) Overlapping retrovirus U5 sequence elements are required for efficient integration and initiation of reverse transcription. J. Virol., 65, 3864-3872.
15. Lys3. J. Virol., 69, 3090-3097.
16. Dayton, A.I., Sodroski, J.G., Rosen, C.A., Goh, W.C. and Haseltine, W.A. (1986) The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell, 44, 941-947.
17. Dingwall, C., Ernberg, I., Gait, M.J., Green, S.M., Heaphy, S., Karn, J., Lowe, A.D., Singh, M. and Skinner, M.A. (1990) HIV-1 Tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J., 9, 4145-4153.
18. Feinberg, M.B., Baltimore, D. and Frankel, A.D. (1991) The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl Acad. Sci. USA, 88, 4045-4049.
19. Feng, S. and Holland, E.C. (1988) HIV-1 Tat trans-activation requires the loop sequence within TAR. Nature, 334, 165-167.
20. Fisher, A.G. et al. (1986) The trans-activator gene of HTLV-III is essential for virus replication. Nature, 320, 367-371.
21. Franke, E.K., Yuan, H.E.H. and Luban, J. (1994) Specific incorporation of cyclophilin A into HIV-1 virions. Nature, 372, 359-362.
22. Garcia, J.A., Harrich, D., Pearson, L., Mitsuyasu, R. and Gaynor, R.B. (1988) Functional domains required for tat-induced transcriptional activation of the HIV-1 long terminal repeat. EMBO J., 7, 3143-3147.
23. Garcia, J.A., Harrich, D., Soultanakis, E., Wu, F., Mitsuyasu, R. and Gaynor, R.B. (1989) Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. EMBO J., 8, 765-778.
24. Goff, S.P. (1990) Retroviral reverse transcriptase: synthesis, structure, and function. J. AIDS, 3, 817-831.
25. Graham, F.L., Smiley, J., Russell, W.C. and Nairn, R. (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen Virol., 36, 59-72.
26. Hahn, B.H., Shaw, G.M., Arya, S.K., Popovic, M., Gallo, R.C. and Wong, S.F. (1984) Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature, 312, 166-169.
27. Harrich, D., Hsu, C. Race, E. and Gaynor, R.B. (1994) Differential growth kinetics are exhibited by human immunodeficiency virus type 1 TAR mutants. J. Virol., 68, 5899-5910.
28. Harrich, D., Mavankal, G., Mette-Snider, A. and Gaynor, R.B. (1995) Human immunodeficiency virus type 1 TAR element revertant viruses define RNA structures required for efficient viral gene expression and replication. J. Virol., 69, 4906-4913.
29. Harrich, D., Ulich, C. and Gaynor, R.B. (1996) A critical role for the TAR element in promoting efficient human immunodeficiency virus type 1 reverse transcription. J. Virol., 70, 4017-4027.
30. Hirt, B. (1967) Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol., 26, 365-369.
31. Hu, W.S. and Temin, H.M. (1990a) Retroviral recombination and reverse transcription. Science, 250, 1227-1233.
32. Hu, W.S. and Temin, H.M. (1990b) Genetic consequence of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genomic recombination. Proc. Natl Acad. Sci. USA. 87, 1556-1560.
33. Hu, Y.F., Luscher, B., Admon, A., Mermod, N. and Tjian, R. (1990) Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity. Genes Dev., 4, 1741-1752.
34. Huang, L., Joshi, A., Willey, R., Orenstein, J. and Jeang, K.T. (1994) Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J., 13, 2886-2896.
35. 3Lys modulate primer/template loop-loop interaction in the initiation complex of HIV-1 reverse transcriptase. J. Biol. Chem., 268, 25269-25272.
36. Isel, C., Ehresmann, C., Keith, G., Ehresmann, B. and Marquet, R. (1995) Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNA(Lys3) (template/primer) complex. J. Mol. Biol., 247, 236-250.
37. Lys. EMBO J., 15, 917-924.
38. Jardine, D., Tachedjian, G., Locarnihi, S. and Birch, C. (1993) Cellular topoisomerase I activity associated with HIV-1. AIDS Res. Hum. Retroviruses, 9, 1245-1250.
39. Kao, S.Y., Calman, A.F., Luciw, P.A. and Peterlin, B.M. (1987) Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature, 330, 489-493.
40. Kato, H., Sumimoto, H., Pognonec, P., Chen, C.H., Rosen, C.A. and Roeder, R.G. (1992) HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. Genes Dev., 6, 655-666.
41. Keen, N.J., Gait, M.J. and Karn, J. (1996) Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. Proc. Natl Acad. Sci. USA, 93, 2505-2510.
42. Klaver, B. and Berkhout, B. (1994) Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. EMBO J., 13, 2650-2659.
43. Kliewer, S., Garcia, J., Pearson, L., Soultanakis, E., Dasgupta, A. and Gaynor, R. (1989) Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity. J. Virol., 63, 4616-4625.
44. Lapadat-Tapolsky, M., De Rocoquigny, H., Van Gent, D., Roques, B., Plasterk, R. and Darlix, J.L. (1993) Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. Nucleic Acids Res., 21, 831-839.
45. Lapadat-Tapolsky, M., Pernelle, C., Borie, C. and Darlix, J.-L. (1995) Analysis of the nucleic acid annealing activities of nucleocapsid protein from HIV-1. Nucleic Acids Res., 23, 2434-2441.
46. Laspia, M.F., Rice, A.P. and Mathews, M.B. (1989) HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell, 59, 283-292.
47. Laspia, M., Rice, A. and Mathews, M.B. (1990) Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcripitonal elongation. Genes Dev., 4, 2397-2408.
48. Li, X., Mak, J., Arts, E.J., Gu, Z., Kleiman, L., Wainberg, M.A. and Parniak, M.A. (1994) Effects of alterations of the primer-binding site sequences on human immunodeficiency virus type 1 replication. J. Virol., 68, 6198-6206.
49. Maddon, P.J., Dalgleish, A.G., McDougal, J.S., Clapham, P.R., Weiss, R.A. and Axel, R. (1986) The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell, 47, 333-348.
50. Marciniak, R.A. and Sharp, P.A. (1991) HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J., 10, 4189-4196.
51. Masuda, T., Planelles, V., Krogstad, P. and Chen, I.S.Y. (1995) Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 an site: unusual phenotype of mutants in the zinc finger-like domain. J. Virol., 69, 6687-6696.
52. Mavankal, G., Du, S.I., Oliver, N., Sigman, D. and Gaynor, R.B. (1996) HIV-1 and HIV-2 Tat proteins specifically interact with RNA polymerase II. Proc. Natl Acad. Sci. USA, 93, 2089-2094.
53. Morgenstern, J.P. and Land, H. (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res., 18, 3587-3596.
54. Muesing, M.A., Smith, D.H. and Capon, D.J. (1987) Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell, 48, 691-701.
55. O'Brian, W.A., Namazi, A., Hamidreza, K., Mao, S.H., Zack, J.A. and Chen, I.S.Y. (1994) Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J. Virol., 68, 1258-1263.
56. Panet, A.C., Haseltine, W.A., Baltimore, D., Peters, G., Harada, F. and Dahlberg, J. (1975) Specific binding of tRNAtrp to AMV reverse transcriptase. Proc. Natl Acad. Sci. USA, 72, 2535-2539.
57. Peliska, J.A., Balasubramanian, S., Giedroc, D.P. and Benovic, S.J. (1994) Recombinant HIV-1 nucleocapsid protein accelerates HIV-1 reverse transcriptase catalyzed DNA strand transfer reactions and modulates RNase H activity. Biochemistry, 33, 13817-13823.
58. Priel, E., Showalter, S.D., Roberts, M., Oroszlan, S., Segal, S., Aboud, M. and Blair, D.G. (1990) Topoisomerase I activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core. EMBO J., 9. 4167-4172.
59. Rhim, H., Park, J. and Morrow, C.D. (1991) Deletions in the tRNA(Lys) primer-binding site of the human immunodeficiency virus type 1 identify essential regions for reverse transcription. J. Virol., 65, 4555-4564.
60. Robert, D., Sallafranque-Andreola, M.L., Bordier, B., Sarih-Cottin, L., Tarrago-Litvak, L., Graves, P.V., Barr, P.J., Fournier, M. and Litvak, S. (1990) Interactions with tRNALys induce important structural changes in human immunodeficiency virus reverse transcriptase. FEBS Lett., 277, 239-242.
61. Rosen, C.A., Sodoroski, J.G. and Haseltine, W.A. (1985) The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell, 41, 813-823.
62. Schwartz, O., Marechal, V., Danos, O. and Heard, J.M. (1995) Human immunodeficiency virus type 1 nef increases the efficiency of reverse transcription in the infected cell. J. Virol., 69, 4053-4059.
63. Selby, M.J., Bain, E.S., Luciw, P.A. and Peterlin, B.M. (1989) Structure, sequence, and position of the stem-loop in TAR determine transcriptional elongation by Tat through the HIV-1 long terminal repeat. Genes Dev., 3, 547-558.
64. Sherman, P.A. and Fyfe, J.A. (1989) Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primers. Anal. Biochem., 180, 222-226.
65. Takahashi, H., Matsuda, M., Kojima, A., Sata, T., Andoh, T. Kurata, T., Nagashima, K. and Hall, W.W. (1995) Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I. Proc. Natl Acad. Sci. USA, 92, 5694-5698.
66. Temin, H.M. and Mitzutani, S. (1970) RNA-directed DNA polymerase in virions of Rous sarcoma virus. Nature, 226, 1211-1213.
67. Thali, M., Bukovsky, A.A., Kondo, E., Rosenwirth, B., Walsh, C.T., Sodroski, J. and Gottlinger, H.G. (1994) Specific association of cyclophilin A with human immunodeficiency virus type 1 virions. Nature, 372, 363-365.
68. Varmus, H. and Brown, P. (1989). Retroviruses. In Berg, D.E. and Howe, M.M. (eds), Mobile DNA. American Society for Microbiology, Washington, DC, pp. 53-108.
69. von Schwedler, U., Song, J., Aiken, C. and Trono, D. (1993) Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol., 67, 5067-5074.
70. Wakefield, J.K., Rhim, H. and Morrow, C.D. (1994) Minimal sequence requirements of a functional immunodeficiency virus type 1 primer binding site. J. Virol., 68, 1605-1614.
71. Wakefield, J.K., Wolf, A.G. and Morrow, C.D. (1995) Human immunodeficiency virus type 1 can use different tRNA as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(Lys3). J. Virol., 69, 6021-6029.
72. Weeks, K.M. and Crothers, D.M. (1991) RNA recognition by Tat-derived peptides: interaction in the major groove? Cell, 66, 577-588.
73. Whitcomb, J.M. and Hughes, S.H. (1992) Retroviral reverse transcription and integration: progress and problems. Annu. Rev. Cell Biol., 8, 275-306.
74. Zack, J.A., Arrigo, S.J., Weitsman, S.R., Go, A.S., Haislip, A.M. and Chen, I.S. (1990) HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell, 61, 213-222.
75. Zack, J.A., Haislip, A.M., Krogstad, P. and Chen, I.S. (1992) Incomplete reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol., 66, 1717-1725.
76. Zakharova, O.D., Tarrago-Litvak, L., Fournier, M., Andreola, M.L., Repkova, M.N., Venyaminova, A.G., Litvak, S. and Nevinsky, G.A. (1995) Interaction of primer tRNA (Lys3) with p51 subunit of human immunodeficiency virus type 1 reverse transcriptase: a possible role in enzyme activation. FEBS Lett., 361, 287-290.